HBIO – harvard bioscience, inc. (US:NASDAQ)
Stock Stats
News
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target lowered by analysts at Benchmark Co. from $5.50 to $4.50. They now have a "speculative buy" rating on the stock.
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting [Yahoo! Finance]
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Form 4 HARVARD BIOSCIENCE INC For: Mar 19 Filed by: Cote Jennifer
Form 4 HARVARD BIOSCIENCE INC For: Mar 19 Filed by: Green James W
Form SCHEDULE 13G HARVARD BIOSCIENCE INC Filed by: Leviticus Partners LP
Form 10-K HARVARD BIOSCIENCE INC For: Dec 31
Form 8-K HARVARD BIOSCIENCE INC For: Mar 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.